Evidence map›Paper›PMID 26806302›Full record

ArticleActa pharmacologica Sinica2016

Schisandrol B protects against acetaminophen-induced acute hepatotoxicity in mice via activation of the NRF2/ARE signaling pathway.

Yi-ming Jiang, Ying Wang, Hua-sen Tan, Tao Yu, Xiao-mei Fan, Pan Chen, Hang Zeng, Min Huang, Hui-chang Bi

Open access · bronzeAbstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
13.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. The promising antioxidant effects of lignans: Nrf2 activation comes into view.Naunyn-Schmiedeberg's archives of pharmacology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Nrf2 Activation Attenuates Acrylamide-Induced Neuropathy in Mice.International journal of molecular sciences · 2021
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yi-ming JiangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Ying WangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Hua-sen TanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Tao YuSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Xiao-mei FanSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Pan ChenSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Hang ZengSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Min HuangSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Hui-chang BiSchool of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
Sun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe nuclear factor erythroid 2-related factor 2 (NRF2) acts through the antioxidant response element (ARE) to regulate the expression of many detoxifying and antioxidant genes responsible for cytoprotective processes. We previously reported that Schisandrol B (SolB) isolated from Schisandra sphenanthera produced a protective effect against acetaminophen (APAP)-induced liver injury. In this study we investigated whether the NRF2/ARE signaling pathway was involved in this hepato-protective effect.

methodsMale C57BL/6 mice were treated with SolB (200 mg · kg(-1) · d(-1), ig) for 3 d before injection of APAP (400 mg/kg, ip). Serum and liver tissue samples were collected 6 h later. The mRNA and protein expression were measured using qRT-PCR and Western blot assay, respectively. The activation of NRF2 was examined in HepG2 cells using luciferase reporter gene assay.

resultsSolB pretreatment significantly alleviated the hepatic injury (large patchy necrosis and hyperemia of the hepatic sinus), the increase of serum AST, ALT levels and hepatic MDA contents, and the decrease of liver and mitochondrial glutathione levels in APAP-treated mice. Furthermore, SolB pretreatment significantly increased nuclear accumulation of NRF2 and increased hepatic expression of NRF2 downstream proteins, including GCLC, GSR, NQO1, GSTs, MRP2, MRP3 and MRP4 in APAP-treated mice. Moreover, treatment with SolB (2.5-20 μmol/L) dose-dependently increased the activity of NRF2 reporter gene in HepG2 cells.

conclusionSolB exhibits a remarkable protective effect against APAP-induced hepatotoxicity, partially via activation of the NRF2/ARE pathway and regulation of NRF2 target genes, which induce detoxification and increase antioxidant capacity.

Indexed as

AcetaminophenAnalgesics, Non-NarcoticAnimalsAntioxidant Response ElementsChemical and Drug Induced Liver InjuryCyclooctanesDioxolesGene Expression RegulationHep G2 CellsHumansLignansLiverMaleMiceMice, Inbred C57BLNF-E2-Related Factor 2AcetaminophenAnalgesics, Non-NarcoticCyclooctanesDioxolesLignansNF-E2-Related Factor 2Protective AgentsRNA, Messengerschizandrol B

Identifiers

PMID26806302
PMCPMC4775844
OpenAlexW2271776986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.